175 related articles for article (PubMed ID: 12709723)
1. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation.
Heikkinen T; Ekblad U; Palo P; Laine K
Clin Pharmacol Ther; 2003 Apr; 73(4):330-7. PubMed ID: 12709723
[TBL] [Abstract][Full Text] [Related]
2. Citalopram in pregnancy and lactation.
Heikkinen T; Ekblad U; Kero P; Ekblad S; Laine K
Clin Pharmacol Ther; 2002 Aug; 72(2):184-91. PubMed ID: 12189365
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
Kim J; Riggs KW; Misri S; Kent N; Oberlander TF; Grunau RE; Fitzgerald C; Rurak DW
Br J Clin Pharmacol; 2006 Feb; 61(2):155-63. PubMed ID: 16433870
[TBL] [Abstract][Full Text] [Related]
4. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
[TBL] [Abstract][Full Text] [Related]
5. Distribution and excretion of fluoxetine and norfluoxetine in human milk.
Kristensen JH; Ilett KF; Hackett LP; Yapp P; Paech M; Begg EJ
Br J Clin Pharmacol; 1999 Oct; 48(4):521-7. PubMed ID: 10583022
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk.
Hendrick V; Stowe ZN; Altshuler LL; Mintz J; Hwang S; Hostetter A; Suri R; Leight K; Fukuchi A
Biol Psychiatry; 2001 Nov; 50(10):775-82. PubMed ID: 11720696
[TBL] [Abstract][Full Text] [Related]
7. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk.
Taddio A; Ito S; Koren G
J Clin Pharmacol; 1996 Jan; 36(1):42-7. PubMed ID: 8932542
[TBL] [Abstract][Full Text] [Related]
8. Estimates of nursing infant daily dose of fluoxetine through breast milk.
Suri R; Stowe ZN; Hendrick V; Hostetter A; Widawski M; Altshuler LL
Biol Psychiatry; 2002 Sep; 52(5):446-51. PubMed ID: 12242061
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders.
Sagahón-Azúa J; Medellín-Garibay SE; Chávez-Castillo CE; González-Salinas CG; Milán-Segovia RDC; Romano-Moreno S
Pharmacol Res Perspect; 2021 Oct; 9(5):e00864. PubMed ID: 34523245
[TBL] [Abstract][Full Text] [Related]
10. Population PK modelling and simulation based on fluoxetine and norfluoxetine concentrations in milk: a milk concentration-based prediction model.
Tanoshima R; Bournissen FG; Tanigawara Y; Kristensen JH; Taddio A; Ilett KF; Begg EJ; Wallach I; Ito S
Br J Clin Pharmacol; 2014 Oct; 78(4):918-28. PubMed ID: 24773313
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.
Jannuzzi G; Gatti G; Magni P; Spina E; Pacifici R; Zuccaro P; Torta R; Guarneri L; Perucca E
Ther Drug Monit; 2002 Oct; 24(5):616-27. PubMed ID: 12352933
[TBL] [Abstract][Full Text] [Related]
12. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
Kandasamy M; Tripathy K; Ravi S; Kamath N; Pai B; Srinivas NR; Kristjansson F; Thangam S
Arzneimittelforschung; 2010; 60(1):12-21. PubMed ID: 20184222
[TBL] [Abstract][Full Text] [Related]
13. Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
Keck PE; McElroy SL
J Clin Psychiatry; 1992 Apr; 53(4):127-9. PubMed ID: 1564047
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.
Tomson T; Palm R; Källén K; Ben-Menachem E; Söderfeldt B; Danielsson B; Johansson R; Luef G; Ohman I
Epilepsia; 2007 Jun; 48(6):1111-6. PubMed ID: 17381438
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine in breast-milk and developmental outcome of breast-fed infants.
Yoshida K; Smith B; Craggs M; Kumar RC
Br J Psychiatry; 1998 Feb; 172():175-8. PubMed ID: 9519072
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine/norfluoxetine concentrations in human milk.
Burch KJ; Wells BG
Pediatrics; 1992 Apr; 89(4 Pt 1):676-7. PubMed ID: 1557252
[No Abstract] [Full Text] [Related]
17. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
Amsterdam JD; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Michelson D; Hornig-Rohan M; Beasley CM
Am J Psychiatry; 1997 Jul; 154(7):963-9. PubMed ID: 9210747
[TBL] [Abstract][Full Text] [Related]
19. Red cell and plasma concentrations of fluoxetine and norfluoxetine.
Amitai Y; Kennedy E; DeSandre P; Fawcett J; Frischer H
Vet Hum Toxicol; 1993 Apr; 35(2):134-6. PubMed ID: 8470355
[TBL] [Abstract][Full Text] [Related]
20. Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins. Consequences for longterm neurological and cognitive development of the child lactation.
Boersma ER; Lanting CI
Adv Exp Med Biol; 2000; 478():271-87. PubMed ID: 11065080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
